Comparative Proteomics of Outer Membrane Vesicles from Polymyxin-Susceptible and Extremely Drug-Resistant Klebsiella pneumoniae
暂无分享,去创建一个
J. Li | T. Velkov | M. Baker | Maytham H Hussein | G. Rao | J. Ziogas | Varsha J. Thombare | Raad Jasim | Hakan Gocol | Aayush Purohit
[1] J. Li,et al. Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant Klebsiella pneumoniae , 2022, Computational and structural biotechnology journal.
[2] L. Altucci,et al. Outer Membrane Vesicles Derived from Klebsiella pneumoniae Are a Driving Force for Horizontal Gene Transfer , 2021, bioRxiv.
[3] Woojun Park,et al. A novel decoy strategy for polymyxin resistance in Acinetobacter baumannii , 2021, eLife.
[4] J. Li,et al. Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens , 2020, Computational and structural biotechnology journal.
[5] Anastasiya A. Yakhnina,et al. The Tol-Pal system is required for peptidoglycan-cleaving enzymes to complete bacterial cell division , 2020, Proceedings of the National Academy of Sciences.
[6] D. Kahne,et al. Formation of a β-barrel membrane protein is catalyzed by the interior surface of the assembly machine protein BamA , 2019, eLife.
[7] L. Patro,et al. Targeting the Sugary Armor of Klebsiella Species , 2019, Front. Cell. Infect. Microbiol..
[8] Kang Yao,et al. Quorum Sensing: A Prospective Therapeutic Target for Bacterial Diseases , 2019, BioMed research international.
[9] D. Hoyer,et al. A Comparative Study of Outer Membrane Proteome between Paired Colistin-Susceptible and Extremely Colistin-Resistant Klebsiella pneumoniae Strains. , 2018, ACS infectious diseases.
[10] Z. Jia,et al. Structural Basis for the Lipopolysaccharide Export Activity of the Bacterial Lipopolysaccharide Transport System , 2018, International journal of molecular sciences.
[11] David A. Dik,et al. Exolytic and endolytic turnover of peptidoglycan by lytic transglycosylase Slt of Pseudomonas aeruginosa , 2018, Proceedings of the National Academy of Sciences.
[12] C. Dean,et al. LpxK Is Essential for Growth of Acinetobacter baumannii ATCC 19606: Relationship to Toxic Accumulation of Lipid A Pathway Intermediates , 2017, mSphere.
[13] The UniProt Consortium. UniProt: the universal protein knowledgebase , 2016, Nucleic Acids Res..
[14] M. Otto,et al. Bacterial strategies of resistance to antimicrobial peptides , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.
[15] P. Sergiev,et al. Regulation of flagellar gene expression in Bacteria , 2015, Biochemistry (Moscow).
[16] M. Kuehn,et al. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions , 2015, Nature Reviews Microbiology.
[17] J. Rossen,et al. An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[18] J. Rossen,et al. An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[19] Victor I Band,et al. Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria , 2014, Antibiotics.
[20] P. Nordmann,et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. , 2015, The Journal of antimicrobial chemotherapy.
[21] Serge Morand,et al. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria , 2014, Front. Microbiol..
[22] S. Brisse,et al. Genomic Definition of Hypervirulent and Multidrug-Resistant Klebsiella pneumoniae Clonal Groups , 2014, Emerging infectious diseases.
[23] S. Siadat,et al. High rate of aminoglycoside resistance in CTX-M-15 producing Klebsiella pneumoniae isolates in Tehran, Iran. , 2014, Laboratory medicine.
[24] Jenn-Kang Hwang,et al. CELLO2GO: A Web Server for Protein subCELlular LOcalization Prediction with Functional Gene Ontology Annotation , 2014, PloS one.
[25] A. Polissi,et al. The Lipopolysaccharide Export Pathway in Escherichia coli: Structure, Organization and Regulated Assembly of the Lpt Machinery , 2014, Marine drugs.
[26] M. Jagannadham,et al. Molecular characterization and functional analysis of outer membrane vesicles from the antarctic bacterium Pseudomonas syringae suggest a possible response to environmental conditions. , 2014, Journal of proteome research.
[27] Jesmin Akter,et al. A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity , 2013, The Journal of Antibiotics.
[28] E. Groisman,et al. The biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications. , 2013, Annual review of microbiology.
[29] J. Beckwith. The Sec-dependent pathway. , 2013, Research in microbiology.
[30] R. Nation,et al. Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid A , 2013, Innate immunity.
[31] R. Nation,et al. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics. , 2013, Future microbiology.
[32] A. Kuhn,et al. Protein traffic in Gram-negative bacteria--how exported and secreted proteins find their way. , 2012, FEMS microbiology reviews.
[33] R. Hilgenfeld,et al. Structural and mechanistic analysis of the membrane-embedded glycosyltransferase WaaA required for lipopolysaccharide synthesis , 2012, Proceedings of the National Academy of Sciences.
[34] Herman Goossens,et al. Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action , 2012, Antimicrobial Resistance and Infection Control.
[35] S. Auclair,et al. Signal peptidase I: Cleaving the way to mature proteins , 2012, Protein science : a publication of the Protein Society.
[36] Hiroshi Nikaido,et al. Efflux-Mediated Drug Resistance in Bacteria , 2012, Drugs.
[37] M. Kuehn,et al. Contribution of bacterial outer membrane vesicles to innate bacterial defense , 2011, BMC Microbiology.
[38] Samuel I. Miller,et al. PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients , 2011, Antimicrobial Agents and Chemotherapy.
[39] A. H. Wang,et al. Conformational change upon product binding to Klebsiella pneumoniae UDP-glucose dehydrogenase: a possible inhibition mechanism for the key enzyme in polymyxin resistance. , 2011, Journal of structural biology.
[40] D. Livermore,et al. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. , 2011, The Lancet. Infectious diseases.
[41] N. Woodford,et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.
[42] M. Falagas,et al. Resistance to polymyxins: Mechanisms, frequency and treatment options. , 2010, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[43] Hwei-Ling Peng,et al. Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43 , 2010, Journal of Biomedical Science.
[44] Martin Ester,et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes , 2010, Bioinform..
[45] C. Herrera,et al. Activation of PmrA inhibits LpxT-dependent phosphorylation of lipid A promoting resistance to antimicrobial peptides , 2010, Molecular microbiology.
[46] C. Whitchurch,et al. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells , 2010, Cellular microbiology.
[47] J. Rahimian,et al. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[49] J. Bengoechea,et al. Klebsiella pneumoniae OmpA Confers Resistance to Antimicrobial Peptides , 2008, Antimicrobial Agents and Chemotherapy.
[50] L. Rice,et al. Presence of Plasmid-Mediated Quinolone Resistance in Klebsiella pneumoniae Isolates Possessing blaKPC in the United States , 2008, Antimicrobial Agents and Chemotherapy.
[51] A. Yamaguchi,et al. CRP Regulator Modulates Multidrug Resistance of Escherichia coli by Repressing the mdtEF Multidrug Efflux Genes , 2008, The Journal of Antibiotics.
[52] E. Evdokimova,et al. Structure and Function of Sedoheptulose-7-phosphate Isomerase, a Critical Enzyme for Lipopolysaccharide Biosynthesis and a Target for Antibiotic Adjuvants* , 2008, Journal of Biological Chemistry.
[53] Daniel Kahne,et al. Defining the roles of the periplasmic chaperones SurA, Skp, and DegP in Escherichia coli. , 2007, Genes & development.
[54] A. J. Carpousis. The RNA degradosome of Escherichia coli: an mRNA-degrading machine assembled on RNase E. , 2007, Annual review of microbiology.
[55] Y. Gho,et al. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli , 2007, Proteomics.
[56] C. Raetz,et al. Lipid A modification systems in gram-negative bacteria. , 2007, Annual review of biochemistry.
[57] Ruei-Jiun Hung,et al. Comparative Analysis of Two UDP-glucose Dehydrogenases in Pseudomonas aeruginosa PAO1* , 2007, Journal of Biological Chemistry.
[58] M. McConville,et al. Secondary Acylation of Klebsiella pneumoniae Lipopolysaccharide Contributes to Sensitivity to Antibacterial Peptides* , 2007, Journal of Biological Chemistry.
[59] M. Kuehn,et al. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response , 2007, Molecular microbiology.
[60] D. Kendall,et al. Oligomeric states of the SecA and SecYEG core components of the bacterial Sec translocon. , 2007, Biochimica et biophysica acta.
[61] E. Groisman,et al. The PmrA/PmrB and RcsC/YojN/RcsB systems control expression of the Salmonella O‐antigen chain length determinant , 2006, Molecular microbiology.
[62] R. Jones,et al. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[63] B. Van Houten,et al. Prokaryotic nucleotide excision repair: the UvrABC system. , 2006, Chemical reviews.
[64] D. Landman,et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. , 2005, The Journal of antimicrobial chemotherapy.
[65] T. Standiford,et al. The Klebsiella pneumoniae O Antigen Contributes to Bacteremia and Lethality during Murine Pneumonia , 2004, Infection and Immunity.
[66] Cathy H. Wu,et al. UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..
[67] M. Regué,et al. Synthesis of a Klebsiella pneumoniae O-Antigen Heteropolysaccharide (O12) Requires an ABC 2 Transporter , 2003, Journal of bacteriology.
[68] K. Otto,et al. Surface sensing and adhesion of Escherichia coli controlled by the Cpx-signaling pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[69] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[70] S. Ealick,et al. The crystal structure of ADP-L-glycero-D-mannoheptose 6-epimerase: catalysis with a twist. , 2000, Structure.
[71] M. Kuehn,et al. Enterotoxigenic Escherichia coli Secretes Active Heat-labile Enterotoxin via Outer Membrane Vesicles* , 2000, The Journal of Biological Chemistry.
[72] E. Groisman,et al. A small protein that mediates the activation of a two‐component system by another two‐component system , 2000, The EMBO journal.
[73] S. Merino,et al. Capsular Polysaccharide Is a Major Complement Resistance Factor in Lipopolysaccharide O Side Chain-DeficientKlebsiella pneumoniae Clinical Isolates , 2000, Infection and Immunity.
[74] N. Høiby,et al. Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. , 2000, The Journal of antimicrobial chemotherapy.
[75] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[76] Samuel I. Miller,et al. Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides , 1998, Cell.
[77] M. Valvano,et al. Biosynthesis of Inner Core Lipopolysaccharide in Enteric Bacteria Identification and Characterization of a Conserved Phosphoheptose Isomerase (*) , 1996, The Journal of Biological Chemistry.
[78] W. Renner,et al. Expression of genes kdsA and kdsB involved in 3-deoxy-D-manno-octulosonic acid metabolism and biosynthesis of enterobacterial lipopolysaccharide is growth phase regulated primarily at the transcriptional level in Escherichia coli K-12 , 1995, Journal of bacteriology.
[79] D. Dorward,et al. Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae , 1989, Journal of bacteriology.
[80] D. Feingold,et al. The mechanism of polymyxin B action and selectivity toward biologic membranes. , 1973, Biochemistry.